BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6199622)

  • 1. A new 111In-bleomycin complex for tumor imaging: preparation, stability, and distribution in glioma-bearing mice.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Farkas RJ; Miller EE
    J Surg Oncol; 1984 Mar; 25(3):168-75. PubMed ID: 6199622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of 111In-bleomycin in vivo--properties compared with 57Co-bleomycin.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
    Eur J Nucl Med; 1983; 8(12):535-40. PubMed ID: 6199207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and stability of [111In]bleomycin and its fractions in tumor-bearing mice.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
    Int J Nucl Med Biol; 1984; 11(2):129-39. PubMed ID: 6207129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new tumor imaging agent--111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-bleomycin in tumor-bearing animals.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Miller EE; Larson SM
    J Surg Oncol; 1984 Nov; 27(3):189-95. PubMed ID: 6208427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new 111In-bleomycin complex for combined radiotherapy and chemotherapy.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Farkas RJ; Miller EE; Larson SM
    J Surg Oncol; 1985 Jun; 29(2):91-8. PubMed ID: 2417055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 111In-bleomycin for combining radiotherapy and chemotherapy on glioma-bearing mice.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
    J Surg Oncol; 1985 Jun; 29(2):71-7. PubMed ID: 2417054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced killing of human small cell lung cancer by hyperthermia and indium-111-bleomycin complex.
    Hou DY; Maruyama Y
    J Surg Oncol; 1990 May; 44(1):5-9. PubMed ID: 1692949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killing of human lung cancer cells using a new [111In]bleomycin complex [111In]BLMC.
    Hou DY; Hamburger AW; Beach JL; Maruyama Y
    Cancer Invest; 1989; 7(6):543-50. PubMed ID: 2483533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low pH 111In-bleomycin complex: a tracer for radiochemotherapy of head and neck cancer.
    Kairemo KJ; Ramsay H; Nikula TK; Hopsu EV; Taavitsainen MJ; Bondestam S; Hiltunen JV
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):135-9. PubMed ID: 7543289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of female genital malignant tumors by using 111In-bleomycin scintigraphy.
    Kida T; Ikeda M; Saito M
    Radioisotopes; 1978 Sep; 27(9):514-9. PubMed ID: 82980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome aberrations of human small cell lung cancer induced by a new 111In-bleomycin complex.
    Hou DY; Maruyama Y; Drago JR
    J Surg Oncol; 1992 Dec; 51(4):236-42. PubMed ID: 1279317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of 111In-labeled bleomycin in patients with brain tumors: compartmental vs. non-compartmental models.
    Ryynänen PM; Savolainen SE; Aronen HJ; Korppi-Tommola ET; Huhmar HM; Kallio ME; Hiltunen JV
    Ann Nucl Med; 1998 Dec; 12(6):313-21. PubMed ID: 9972368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of radio-labelled bleomycin for tumor detection.
    Rasker JJ; Beekhuis H; van de Poll MA; Versluis A; Jurjens H; Woldring MG
    Nuklearmedizin; 1978 Dec; 17(6):238-48. PubMed ID: 84374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution study using 57Co-, 51Cr-, 111In- and 99mTc-bleomycin in mice with a solid Ehrlich carcinoma].
    Zimmermann M; Hale T
    Nuklearmedizin; 1976 Aug; 15(4):176-82. PubMed ID: 62345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of chemotherapy on the distribution of 57Co-bleomycin in chemically induced squamous cell carcinoma of mouse skin.
    Pertynski T; Reznik G; Mariss P; Ketkar MB; Haindl H; Dieffenbach G
    Eur J Nucl Med; 1979 Feb; 4(1):55-9. PubMed ID: 91511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic activity, tumor accumulation, and tissue distribution of ruthenium-103-labeled bleomycin.
    Stern PH; Helpern SE; Hagan PL; Howell SB; Dabbs JE; Gordon RM
    J Natl Cancer Inst; 1981 May; 66(5):807-11. PubMed ID: 6164811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice.
    Krohn KA; Meyers JM; DeNardo GL; DeNardo SJ
    J Nucl Med; 1977 Mar; 18(3):276-81. PubMed ID: 65460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killing lung cancer cells at cell-cycle phase by a new indium-111-bleomycin complex.
    Hou DY; Ordonez JV; Cross RJ; Ross DD; Maruyama Y
    J Surg Oncol; 1989 Feb; 40(2):73-8. PubMed ID: 2464720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of 111In-bleomycin complex in small cell lung cancer cells by autoradiography.
    Hou DY; Maruyama Y
    J Surg Oncol; 1992 Feb; 49(2):93-7. PubMed ID: 1371176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of indium-111 BLEDTA in man.
    Sartoris DJ; Goodwin DA; Meares CF; DeRiemer LH; Fajardo LF
    Invest Radiol; 1984; 19(3):221-7. PubMed ID: 6206021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.